ArticleClinical case reports2026
Synchronous Vaginal and Liver Metastases in Rectosigmoid Cancer: Case Report and Literature Review.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaginal metastasis from colorectal cancer is extremely rare. We report the case of a 58-year-old postmenopausal woman with rectosigmoid adenocarcinoma and synchronous liver and vaginal metastases who initially presented with gastrointestinal symptoms followed by vaginal bleeding. The diagnosis was established through colonoscopy, biopsy, CT, MRI, and FDG PET-CT. After 6 cycles of FOLFOX chemotherapy, the liver metastases regressed, while the primary tumor and vaginal lesions progressed. She subsequently underwent pelvic exenteration with ileal conduit formation and right hepatectomy, followed by pulmonary metastasectomy and stereotactic body radiotherapy for subsequent lung metastases. At 41 months of follow-up from diagnosis, the patient remains alive with disease and has demonstrated a favorable response to multimodal therapy. This case highlights the importance of gynecological evaluation in female patients with colorectal cancer and demonstrates that aggressive multimodal management can achieve prolonged disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.